Homology Medicines to Participate in Upcoming Investor and Scientific Conferences
(World News Science)

BEDFORD, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following investor and scientific conferences: BTIG Targeted Therapeutics Conference at The St. Regis New York Panel presentation, `Gene Therapy: How Do You Build More Than a One-Stop-Shop to Derive Value?`: February 24 at 10:00 a.m. ET...